Skip to main content
Premium Trial:

Request an Annual Quote

U. of Cambridge, Cancer Research UK, Perlegen Team Up for Breast Cancer Genotyping Study

NEW YORK, Feb. 16 (GenomeWeb News) - Researchers at the University of Cambridge, UK, Cancer Research UK and its technology transfer arm, and Perlegen Sciences will collaborate in a genotyping study to find genetic variations associated with breast cancer, the institutions said today.


Cancer Research UKprovides the funding for the project.


Perlegen Sciences will determine over 200 million genotypes in DNA samples collected from breast cancer patients in the UKand healthy women enrolled in the European Prospective Investigation of Cancer study. Initial results will be validated by Cambridgeresearchers, who plan to analyze several thousand additional samples.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.